US Stock Futures Down; Powell Testimony In Focus
Pre-open movers
U.S. stock futures traded lower in early pre-market trade after the Dow Jones gained more than 600 points in the previous session.
Analyst Ratings for Enviva
Analysts have provided the following ratings for Enviva (NYSE:EVA) within the last quarter:
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Analyst Ratings for Enviva
Analysts have provided the following ratings for Enviva (NYSE:EVA) within the last quarter:
Here’s How Much $1000 Invested In Enviva 5 Years Ago Would Be Worth Today
Enviva (NYSE:EVA) has outperformed the market over the past 5 years by 9.02% on an annualized basis producing an average annual return of 22.72%. Currently, Enviva has a market capitalization of $5.40 billion.
Enviva Reports $250M Investment In New Production Plant For Bond, Mississippi
Fully Contracted Plant Will Serve International Demand for Secure Sources of Renewable Energy and Help Decarbonize Difficult-to-Abate Industries such as Steel, Cement, Lime, and Sustainable Aviation Fuels
BETHESDA,
Raymond James Downgrades Enviva to Market Perform
Raymond James analyst Pavel Molchanov downgrades Enviva (NYSE:EVA) from Outperform to Market Perform.
Peering Into Enviva Partners Lpunits Representing Limi’s Recent Short Interest
Enviva Partners Lpunits Representing Limi's (NYSE:EVA) short percent of float has risen 5.51% since its last report. The company recently reported that it has 786.10 thousand shares sold short, which is 2.68% of all regular shares that are available for trading.